16-19115207-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001034841.4(ITPRIPL2):c.746C>T(p.Thr249Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,609,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001034841.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPRIPL2 | ENST00000381440.5 | c.746C>T | p.Thr249Ile | missense_variant | Exon 1 of 1 | 6 | NM_001034841.4 | ENSP00000370849.3 | ||
ITPRIPL2 | ENST00000566735.1 | n.760C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
ENSG00000261427 | ENST00000564808.6 | n.418+272C>T | intron_variant | Intron 2 of 5 | 4 | |||||
ENSG00000261427 | ENST00000568526.1 | n.211+422C>T | intron_variant | Intron 2 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248066Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134564
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1456764Hom.: 0 Cov.: 31 AF XY: 0.0000455 AC XY: 33AN XY: 725008
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.746C>T (p.T249I) alteration is located in exon 1 (coding exon 1) of the ITPRIPL2 gene. This alteration results from a C to T substitution at nucleotide position 746, causing the threonine (T) at amino acid position 249 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at